Gemphire Therapeutics Stock Filter Stocks by Fundamentals
Gemphire Therapeutics fundamentals help investors to digest information that contributes to Gemphire Therapeutics' financial success or failures. It also enables traders to predict the movement of Gemphire Stock. The fundamental analysis module provides a way to measure Gemphire Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gemphire Therapeutics stock.
Gemphire |
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
All Next | Launch Module |
Gemphire Fundamentals
Return On Equity | -280.97 | |||
Return On Asset | -44.9 | |||
Current Valuation | 109.69 M | |||
Shares Outstanding | 14.87 M | |||
Shares Owned By Insiders | 55.90 % | |||
Shares Owned By Institutions | 17.95 % | |||
Number Of Shares Shorted | 142.79 K | |||
Price To Earning | (2.89) X | |||
Price To Book | 2.46 X | |||
EBITDA | (12.09 M) | |||
Net Income | (13.81 M) | |||
Cash And Equivalents | 1.85 M | |||
Cash Per Share | 0.12 X | |||
Debt To Equity | 0.90 % | |||
Current Ratio | 0.67 X | |||
Book Value Per Share | (0.07) X | |||
Cash Flow From Operations | (10.94 M) | |||
Short Ratio | 0.82 X | |||
Earnings Per Share | (0.97) X | |||
Beta | 2.87 | |||
Market Capitalization | 178.47 K | |||
Total Asset | 15.39 M | |||
Retained Earnings | (63.64 M) | |||
Working Capital | 8.08 M | |||
Current Asset | 14.94 M | |||
Current Liabilities | 6.86 M | |||
Z Score | -5.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Gemphire Stock
If you are still planning to invest in Gemphire Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemphire Therapeutics' history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |